AAAAAA

   
Results: 1-24 |
Results: 24
Imaging tumors with peptide-based radioligands
Authors: Behr, TM Gotthardt, M Barth, A Behe, M
Citation: Tm. Behr et al., Imaging tumors with peptide-based radioligands, Q J NUCL M, 45(2), 2001, pp. 189-200
Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?
Authors: Behr, TM Behe, M Jungclas, H Jungclas, H Becker, W Sgouros, G
Citation: Tm. Behr et al., Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?, EUR J NUCL, 28(9), 2001, pp. 1435-1436
Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?
Authors: Behr, TM
Citation: Tm. Behr, Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas?, EUR J NUCL, 28(7), 2001, pp. 939-940
Somatostatin receptor scintigraphy in the management of cerebral malignantectomesenchymoma: a case report
Authors: Papos, M Pekrun, A Herms, JW Behr, TM Meller, J Rustenbeck, HH Kretzschmar, HA Becker, W
Citation: M. Papos et al., Somatostatin receptor scintigraphy in the management of cerebral malignantectomesenchymoma: a case report, PEDIAT RAD, 31(3), 2001, pp. 169-172
Tc-99m-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model
Authors: Gratz, S Behe, M Boerman, OC Kunze, E Schulz, H Eiffert, H O'Reilly, T Behr, TM Angerstein, C Nebendahl, K Kauer, F Becker, W
Citation: S. Gratz et al., Tc-99m-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model, NUCL MED C, 22(9), 2001, pp. 1003-1013
Trastuzumab and breast cancer.
Authors: Behr, TM Behe, M Wormann, B
Citation: Tm. Behr et al., Trastuzumab and breast cancer., N ENG J MED, 345(13), 2001, pp. 995-996
Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction
Authors: Behr, TM Nerurkar, SS Nelson, AH Coatney, RW Woods, TN Sulpizio, A Chandra, S Brooks, DP Kumar, S Lee, JC Ohlstein, EH Angermann, CE Adams, JL Sisko, J Sackner-Bernstein, JD Willette, RN
Citation: Tm. Behr et al., Hypertensive end-organ damage and premature mortality are p38 mitogen-activated protein kinase-dependent in a rat model of cardiac hypertrophy and dysfunction, CIRCULATION, 104(11), 2001, pp. 1292-1298
Imaging in medullary thyroid cancer
Authors: Behr, TM Becker, W
Citation: Tm. Behr et W. Becker, Imaging in medullary thyroid cancer, THYROID CANCER, 2001, pp. 251-273
Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments
Authors: Behr, TM Blumenthal, RD Memtsoudis, S Sharkey, RM Gratz, S Becker, W Goldenberg, DM
Citation: Tm. Behr et al., Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments, CLIN CANC R, 6(12), 2000, pp. 4900-4907
Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies
Authors: Behr, TM Behe, M Lohr, M Sgouros, G Angerstein, C Wehrmann, E Nebendahl, K Becker, W
Citation: Tm. Behr et al., Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies, EUR J NUCL, 27(7), 2000, pp. 753-765
Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure
Authors: Behr, TM Wang, XK Aiyar, N Coatney, RW Li, X Koster, P Angermann, CE Ohlstein, E Feuerstein, GZ Winaver, J
Citation: Tm. Behr et al., Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure, CIRCULATION, 102(11), 2000, pp. 1315-1322
Increased serum CEA levels as an early symptom of medullary thyroid cancer
Authors: Behr, TM
Citation: Tm. Behr, Increased serum CEA levels as an early symptom of medullary thyroid cancer, DEUT MED WO, 124(10), 1999, pp. 303-304
Diagnostic applications of radiolabeled peptides in nuclear endocrinology
Authors: Behr, TM Behe, M Becker, W
Citation: Tm. Behr et al., Diagnostic applications of radiolabeled peptides in nuclear endocrinology, Q J NUCL M, 43(3), 1999, pp. 268-280
Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters
Authors: Behr, TM Sgouros, G Stabin, MG Behe, M Angerstein, C Blumenthal, RD Apostolidis, C Molinet, R Sharkey, RM Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters, CLIN CANC R, 5(10), 1999, pp. 3031S-3043S
Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential
Authors: Behr, TM Behe, M Angerstein, C Gratz, S Mach, R Hagemann, L Jenner, N Stiehler, M Frank-Raue, K Raue, F Becker, W
Citation: Tm. Behr et al., Cholecystokinin-B/gastrin receptor binding peptides: Preclinical development and evaluation of their diagnostic and therapeutic potential, CLIN CANC R, 5(10), 1999, pp. 3124S-3138S
Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study
Authors: Behr, TM Salib, AL Liersch, T Behe, M Angerstein, C Blumenthal, RD Fayyazi, A Sharkey, RM Ringe, B Becker, H Wormann, B Hiddemann, W Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Radioimmunotherapy of small volume disease of colorectal cancer metastaticto the liver: Preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study, CLIN CANC R, 5(10), 1999, pp. 3232S-3242S
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies
Authors: Behr, TM Wormann, B Gramatzki, M Riggert, J Gratz, S Behe, M Griesinger, F Sharkey, RM Kolb, HJ Hiddemann, W Goldenberg, DM Becker, W
Citation: Tm. Behr et al., Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies, CLIN CANC R, 5(10), 1999, pp. 3304S-3314S
Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies
Authors: Behr, TM Feucht, HE Richter, K Reiter, C Spes, CH Pongratz, D Uberfuhr, P Meiser, B Theisen, K Angermann, CE
Citation: Tm. Behr et al., Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies, J HEART LUN, 18(9), 1999, pp. 904-912
Metabolic and receptor imaging of metastatic medullary thyroid cancer: does anti-CEA and somatostatin-receptor scintigraphy allow for prognostic predictions?
Authors: Behr, TM Becker, W
Citation: Tm. Behr et W. Becker, Metabolic and receptor imaging of metastatic medullary thyroid cancer: does anti-CEA and somatostatin-receptor scintigraphy allow for prognostic predictions?, EUR J NUCL, 26(1), 1999, pp. 70-71
Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis
Authors: Gratz, S Gobel, D Behr, TM Herrmann, A Becker, W
Citation: S. Gratz et al., Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis, J RHEUMATOL, 26(6), 1999, pp. 1242-1249
Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: Preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial
Authors: Behr, TM Memtsoudis, S Vougioukas, V Liersch, T Gratz, S Schmidt, F Lorf, T Post, S Wormann, B Hiddemann, W Ringe, B Becker, W
Citation: Tm. Behr et al., Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: Preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial, ANTICANC R, 19(4A), 1999, pp. 2427-2432
Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors
Authors: Behr, TM Jenner, N Behe, M Angerstein, C Gratz, S Raue, F Becker, W
Citation: Tm. Behr et al., Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors, J NUCL MED, 40(6), 1999, pp. 1029-1044
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of Bi-213- versus Y-90-labeled CO17-1A Fab ' fragments in a human colonic cancer model
Authors: Behr, TM Behe, M Stabin, MG Wehrmann, E Apostolidis, C Molinet, R Strutz, F Fayyazi, A Wieland, E Gratz, S Koch, L Goldenberg, DM Becker, W
Citation: Tm. Behr et al., High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of Bi-213- versus Y-90-labeled CO17-1A Fab ' fragments in a human colonic cancer model, CANCER RES, 59(11), 1999, pp. 2635-2643
Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin
Authors: Gratz, S Behr, TM Herrmann, A Meller, J Conrad, M Zappel, H Becker, W
Citation: S. Gratz et al., Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin, NUCL MED C, 19(11), 1998, pp. 1037-1045
Risultati: 1-24 |